El F. Hinde et al. / Open Journal of Obstetrics and Gynecology 2 (2012) 279-282
Copyright © 2012 SciRes.
282
somatic alterations of c-KIT is currently ongoing at six
institutions, including Memorial Sloan-Kettering Cancer
Center.
Primary malignant melanoma of female genital tract is
a rare disease with a poor prognosis, especially if it is not
detected in a timely fashion or if it is not treated correctly.
To date, no consensus has been established concerning
treatment of gynecologic primary Melanoma. But it is
recommended that this be surgical, procuring the estab-
lishment of 2-cm margins, accompanied by radio- or
chemo-therapy.
OPEN ACCESS
REFERENCES
[1] Seetharamu, N., Ott, P.A. and Pavlick, A.C. (2010) Mu-
cosal melanomas: A case-based review of the literature.
The Oncologist, 15, 772-781.
doi:10.1634/theoncologist.2010-0067
[2] Irvin Jr, W.P., Bliss, S.A., Rice, L.W., Taylor Jr, P.T. and
Andersen, W.A. (1998) Malignant melanoma of the va-
gina and locoregional control: Radical surgery revisited.
Gynecologic Oncology, 71, 476-480.
doi:10.1006/gyno.1998.5188
[3] Bonner, J.A., Perez-Ta mayo, C., Reid, G.C., Roberts, J.A.
and Morley, G.W. (1988) The management of vaginal
melanoma. Cancer, 62, 2066-2072.
doi:10.1002/1097-0142(19881101)62:9<2066::AID-CNC
R2820620933>3.0.CO;2-D
[4] Siozos, C., Bhat, A., Lonsdale, R., Nieto, J.J. and Crocker,
S.G. (2005) Malignant melanoma of the uterine cervix.
Journal of Obstetrics and Gynaecology, 25, 826-827.
doi:10.1080/01443610500338305
[5] Hewitt P. Sequel to a case of recurrent melanosis of both
groins and back: The disease reappearing in the brain,
heart, pancreas, liver and other organs. Lancet, 1861,
263-264.
[6] Gupta, R., Singh, S. and Mandal, A.K. (2005) Primary
malignant melanoma of cervix—A case report. Indian
Journal of Cancer, 42, 201-204.
[7] Piura, B. (2008) Management of primary melanoma of
the female urogenital tract. The Lancet Oncology, 9, 973-
981. doi:10.1016/S1470-2045(08)70254-7
[8] Deshpande, A.H. and Munshi, M.M. (2001) Primary ma-
lignant melanoma of the uterine cervix: Report of a case
diagnosed by cervical scrape cytology and review of the
literature. Diagnostic Cytopathology, 25, 108-111.
doi:10.1002/dc.2014
[9] Baruah, J., Roy, K.K., Kumar, S. and Kumar, L. (2009) A
rare case of primary malignant melanoma of cervix. Ar-
chives of Gynecology and Obstetrics, 280, 453-456.
doi:10.1007/s00404-008-0912-0
[10] An, J., Li, B., Wu, L., Lu, H. and Li, N. (2009) Primary
malignant amelanotic melanoma of the female genital
tract: Report of two cases and review of literature. Mela-
noma Research, 19, 267-270.
doi:10.1097/CMR.0b013e32831993de
[11] Mousavi, A.S., Fakor, F., Nazari, Z., Ghae mmaghami, F.,
Hashemi, F.A. and Jamali, M. (2006) Primary malignant
melanoma of the uterine cervix: Case report and review
of the literature. Journal of Lower Genital Tract Disease,
10, 258-263. doi:10.1097/01.lgt.0000229564.11741.4e
[12] Wasef, W.R., Roberts, J.K. and Dixon, G.R. (1999) Pri-
mary malignant melanoma of the cervix uteri. Journal of
Obstetrics and Gynaecology, 19, 673-674.
doi:10.1080/01443619964094
[13] Cantuaria, G., Angioli, R., Nahmias, J., Estape, R. and
Penalver, M. (1999) Primarymalignant melanoma of the
uterine cervix: Case report and review of the literature.
Gynecologic Oncology, 75, 170-174.
doi:10.1006/gyno.1999.5491
[14] Miner, T.J., Delgado, R., Zeisler, J., et al. (2004) Primary
vaginal melanoma: A critical analysis of therapy. Annals
of Surgical Oncology, 11, 34-39.
doi:10.1007/BF02524343
[15] Clark, K.C., Butz, W.R. and Hapke, M.R. (1999) Primary
malignant melanoma of the uterine cervix: Case report
with world literature review. International Journal of Gy-
necological Pathology 18, 265-273.
doi:10.1097/00004347-199907000-00013
[16] Curtin, J.A., Busam, K., Pinkel, D., et al. (2006) Somatic
activation of KIT in distinct subtypes of melanoma.
Journal of Clinical Oncology, 24, 4340-4346.
doi:10.1200/JCO.2006.06.2984
[17] Antonescu, C.R., Busam, K.J., Francone, T.D., et al.
(2007) L576P KIT mutation in anal melanomas correlates
with KIT protein expression and is sensitive to specific
kinase inhibition. International Journal of Cancer, 121,
257-264. doi:10.1002/ijc.22681
[18] Torres-Cabala, C.A., Wang, W.L., Trent, J., et al. (2009)
Correlation between KIT expression and KIT mutation in
melanoma: A study of 173 cases with emphasis on the
acral-lentiginous/mucosal type. Modern Pathology, 22,
1446-1456. doi:10.1038/modpathol.2009.116
[19] Hodi, F.S., Friedlander, P., Corless, C.L., et al. (2008)
Major response to imatinib mesylate in KIT-mutated
melanoma. Journal of Clinical Oncology, 26, 2046-2051.
doi:10.1200/JCO.2007.14.0707
[20] Lutzky, J., Bauer, J. and Bastian, B.C. (2008) Dose-de-
pendent, complete response to imatinib of a metastatic
mucosal mel anoma with a K642E KIT mutation. Pigment
Cell & Melanoma Research, 21, 492-493.
doi:10.1111/j.1755-148X.2008.00475.x
[21] Jiang, X., Zhou, J., Yuen, N.K., et al. (2008) Imatinib
targeting of KIT-mutant oncoprotein in melanoma. Clini-
cal Cancer Research, 14, 7726-7732.
doi:10.1158/1078-0432.CCR-08-1144